Industry: Service & Software
Published Date: 2024-08-01
Pages: 128 Pages
Report ld: 3267058
Request Sample
Customized Report
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Personalized Psychiatry is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Personalized Psychiatry is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Personalized Psychiatry is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Personalized Psychiatry include COMPASS Pathways, Mindstrong Health, Pear Therapeutics, Cogito, Kaia Health, Sooma, GenoMind, Empatica, Akili Interactive, Neuroverse, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Personalized Psychiatry market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Personalized Psychiatry, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Personalized Psychiatry, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Personalized Psychiatry revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Personalized Psychiatry market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Personalized Psychiatry revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including COMPASS Pathways, Mindstrong Health, Pear Therapeutics, Cogito, Kaia Health, Sooma, GenoMind, Empatica, Akili Interactive, Neuroverse, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Personalized Psychiatry in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Psychiatry companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Psychiatry revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Psychiatry Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Depression and Anxiety
1.2.3 Bipolar Disorder
1.2.4 Addiction
1.2.5 Other
1.3 Market by Application
1.3.1 Global Personalized Psychiatry Market Share by Application: 2019 VS 2023 VS 2030
1.3.2 Mental Health Professionals
1.3.3 Patients
1.3.4 Healthcare Providers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Psychiatry Market Perspective (2019-2030)
2.2 Global Personalized Psychiatry Growth Trends by Region
2.2.1 Global Personalized Psychiatry Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Personalized Psychiatry Historic Market Size by Region (2019-2024)
2.2.3 Personalized Psychiatry Forecasted Market Size by Region (2025-2030)
2.3 Personalized Psychiatry Market Dynamics
2.3.1 Personalized Psychiatry Industry Trends
2.3.2 Personalized Psychiatry Market Drivers
2.3.3 Personalized Psychiatry Market Challenges
2.3.4 Personalized Psychiatry Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Personalized Psychiatry by Players
3.1.1 Global Personalized Psychiatry Revenue by Players (2019-2024)
3.1.2 Global Personalized Psychiatry Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Psychiatry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Personalized Psychiatry, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Personalized Psychiatry Market Concentration Ratio
3.4.1 Global Personalized Psychiatry Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Psychiatry Revenue in 2023
3.5 Global Key Players of Personalized Psychiatry Head office and Area Served
3.6 Global Key Players of Personalized Psychiatry, Product and Application
3.7 Global Key Players of Personalized Psychiatry, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Psychiatry Breakdown Data by Type
4.1 Global Personalized Psychiatry Historic Market Size by Type (2019-2024)
4.2 Global Personalized Psychiatry Forecasted Market Size by Type (2025-2030)
5 Personalized Psychiatry Breakdown Data by Application
5.1 Global Personalized Psychiatry Historic Market Size by Application (2019-2024)
5.2 Global Personalized Psychiatry Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Personalized Psychiatry Market Size (2019-2030)
6.2 North America Personalized Psychiatry Market Size by Type
6.2.1 North America Personalized Psychiatry Market Size by Type (2019-2024)
6.2.2 North America Personalized Psychiatry Market Size by Type (2025-2030)
6.2.3 North America Personalized Psychiatry Market Share by Type (2019-2030)
6.3 North America Personalized Psychiatry Market Size by Application
6.3.1 North America Personalized Psychiatry Market Size by Application (2019-2024)
6.3.2 North America Personalized Psychiatry Market Size by Application (2025-2030)
6.3.3 North America Personalized Psychiatry Market Share by Application (2019-2030)
6.4 North America Personalized Psychiatry Market Size by Country
6.4.1 North America Personalized Psychiatry Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Personalized Psychiatry Market Size by Country (2019-2024)
6.4.3 North America Personalized Psychiatry Market Share by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Personalized Psychiatry Market Size (2019-2030)
7.2 Europe Personalized Psychiatry Market Size by Type
7.2.1 Europe Personalized Psychiatry Market Size by Type (2019-2024)
7.2.2 Europe Personalized Psychiatry Market Size by Type (2025-2030)
7.2.3 Europe Personalized Psychiatry Market Share by Type (2019-2030)
7.3 Europe Personalized Psychiatry Market Size by Application
7.3.1 Europe Personalized Psychiatry Market Size by Application (2019-2024)
7.3.2 Europe Personalized Psychiatry Market Size by Application (2025-2030)
7.3.3 Europe Personalized Psychiatry Market Share by Application (2019-2030)
7.4 Europe Personalized Psychiatry Market Size by Country
7.4.1 Europe Personalized Psychiatry Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Personalized Psychiatry Market Size by Country (2019-2024)
7.4.3 Europe Personalized Psychiatry Market Size by Country (2025-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.4.9 Nordic Countries
8 China
8.1 China Personalized Psychiatry Market Size (2019-2030)
8.2 China Personalized Psychiatry Market Size by Type
8.2.1 China Personalized Psychiatry Market Size by Type (2019-2024)
8.2.2 China Personalized Psychiatry Market Size by Type (2025-2030)
8.2.3 China Personalized Psychiatry Market Share by Type (2019-2030)
8.3 China Personalized Psychiatry Market Size by Application
8.3.1 China Personalized Psychiatry Market Size by Application (2019-2024)
8.3.2 China Personalized Psychiatry Market Size by Application (2025-2030)
8.3.3 China Personalized Psychiatry Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Personalized Psychiatry Market Size (2019-2030)
9.2 Asia Personalized Psychiatry Market Size by Type
9.2.1 Asia Personalized Psychiatry Market Size by Type (2019-2024)
9.2.2 Asia Personalized Psychiatry Market Size by Type (2025-2030)
9.2.3 Asia Personalized Psychiatry Market Share by Type (2019-2030)
9.3 Asia Personalized Psychiatry Market Size by Application
9.3.1 Asia Personalized Psychiatry Market Size by Application (2019-2024)
9.3.2 Asia Personalized Psychiatry Market Size by Application (2025-2030)
9.3.3 Asia Personalized Psychiatry Market Share by Application (2019-2030)
9.4 Asia Personalized Psychiatry Market Size by Region
9.4.1 Asia Personalized Psychiatry Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Personalized Psychiatry Market Size by Region (2019-2024)
9.4.3 Asia Personalized Psychiatry Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Personalized Psychiatry Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Type
10.2.1 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Personalized Psychiatry Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Application
10.3.1 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Personalized Psychiatry Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Country
10.4.1 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Personalized Psychiatry Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 COMPASS Pathways
11.1.1 COMPASS Pathways Company Details
11.1.2 COMPASS Pathways Business Overview
11.1.3 COMPASS Pathways Personalized Psychiatry Introduction
11.1.4 COMPASS Pathways Revenue in Personalized Psychiatry Business (2019-2024)
11.1.5 COMPASS Pathways Recent Development
11.2 Mindstrong Health
11.2.1 Mindstrong Health Company Details
11.2.2 Mindstrong Health Business Overview
11.2.3 Mindstrong Health Personalized Psychiatry Introduction
11.2.4 Mindstrong Health Revenue in Personalized Psychiatry Business (2019-2024)
11.2.5 Mindstrong Health Recent Development
11.3 Pear Therapeutics
11.3.1 Pear Therapeutics Company Details
11.3.2 Pear Therapeutics Business Overview
11.3.3 Pear Therapeutics Personalized Psychiatry Introduction
11.3.4 Pear Therapeutics Revenue in Personalized Psychiatry Business (2019-2024)
11.3.5 Pear Therapeutics Recent Development
11.4 Cogito
11.4.1 Cogito Company Details
11.4.2 Cogito Business Overview
11.4.3 Cogito Personalized Psychiatry Introduction
11.4.4 Cogito Revenue in Personalized Psychiatry Business (2019-2024)
11.4.5 Cogito Recent Development
11.5 Kaia Health
11.5.1 Kaia Health Company Details
11.5.2 Kaia Health Business Overview
11.5.3 Kaia Health Personalized Psychiatry Introduction
11.5.4 Kaia Health Revenue in Personalized Psychiatry Business (2019-2024)
11.5.5 Kaia Health Recent Development
11.6 Sooma
11.6.1 Sooma Company Details
11.6.2 Sooma Business Overview
11.6.3 Sooma Personalized Psychiatry Introduction
11.6.4 Sooma Revenue in Personalized Psychiatry Business (2019-2024)
11.6.5 Sooma Recent Development
11.7 GenoMind
11.7.1 GenoMind Company Details
11.7.2 GenoMind Business Overview
11.7.3 GenoMind Personalized Psychiatry Introduction
11.7.4 GenoMind Revenue in Personalized Psychiatry Business (2019-2024)
11.7.5 GenoMind Recent Development
11.8 Empatica
11.8.1 Empatica Company Details
11.8.2 Empatica Business Overview
11.8.3 Empatica Personalized Psychiatry Introduction
11.8.4 Empatica Revenue in Personalized Psychiatry Business (2019-2024)
11.8.5 Empatica Recent Development
11.9 Akili Interactive
11.9.1 Akili Interactive Company Details
11.9.2 Akili Interactive Business Overview
11.9.3 Akili Interactive Personalized Psychiatry Introduction
11.9.4 Akili Interactive Revenue in Personalized Psychiatry Business (2019-2024)
11.9.5 Akili Interactive Recent Development
11.10 Neuroverse
11.10.1 Neuroverse Company Details
11.10.2 Neuroverse Business Overview
11.10.3 Neuroverse Personalized Psychiatry Introduction
11.10.4 Neuroverse Revenue in Personalized Psychiatry Business (2019-2024)
11.10.5 Neuroverse Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Personalized Psychiatry market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 121
USD 4900.00
(Single User License)
The global Personalized Psychiatry market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 78
USD 4250.00
(Single User License)
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 89
USD 3950.00
(Single User License)
The global Personalized Psychiatry market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 101
USD 2900.00
(Single User License)
The global Personalized Psychiatry market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 76
USD 4250.00
(Single User License)
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 126
USD 4900.00
(Single User License)
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 84
USD 3950.00
(Single User License)
The global market for Personalized Psychiatry was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-12
Pages: 80
USD 2900.00
(Single User License)
The global Personalized Psychiatry revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-08-01
Pages: 93
USD 4350.00
(Single User License)
The global Personalized Psychiatry market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-08-01
Pages: 71
USD 2900.00
(Single User License)
The global Personalized Psychiatry market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 121
The global Personalized Psychiatry market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 78
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 89
The global Personalized Psychiatry market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 101
The global Personalized Psychiatry market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 76
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 126
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 84
The global market for Personalized Psychiatry was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-12
Pages: 80
The global Personalized Psychiatry revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-08-01
Pages: 93
The global Personalized Psychiatry market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-08-01
Pages: 71
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now